Zhang Q - Search Results

1

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models.

Zhang Q, Zhang H, Ding J, Liu H, Li H, Li H, Lu M, Miao Y, Li L, Zheng J. Zhang Q, et al. Among authors: zhang h. J Immunol Res. 2018 Oct 15;2018:4263520. doi: 10.1155/2018/4263520. eCollection 2018. J Immunol Res. 2018. PMID: 30410941 Free PMC article.

2

Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.

Zhang Q, Liu X, Xu S, Li C, Zhang Y, Yang J, Zheng J. Zhang Q, et al. Among authors: zhang y. Cancer Biother Radiopharm. 2012 Aug;27(6):384-91. doi: 10.1089/cbr.2012.1209. Epub 2012 May 31. Cancer Biother Radiopharm. 2012. PMID: 22651685 Free PMC article.

3

IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation.

Chen F, Song J, Di J, Zhang Q, Tian H, Zheng J. Chen F, et al. Among authors: zhang q. Tumour Biol. 2012 Dec;33(6):2217-25. doi: 10.1007/s13277-012-0483-3. Epub 2012 Aug 14. Tumour Biol. 2012. PMID: 22890831

4

Strategies to improve the clinical performance of chimeric antigen receptor-modified T cells for cancer.

Zhang Q, Li H, Yang J, Li L, Zhang B, Li J, Zheng J. Zhang Q, et al. Among authors: zhang b. Curr Gene Ther. 2013 Feb;13(1):65-70. doi: 10.2174/156652313804806570. Curr Gene Ther. 2013. PMID: 23256743 Review.

5

Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.

Zhang Q, Liu X, Li C, Liao D, Ouyang Z, Zheng J, Song X. Zhang Q, et al. Oncol Lett. 2013 Sep;6(3):801-806. doi: 10.3892/ol.2013.1437. Epub 2013 Jul 3. Oncol Lett. 2013. PMID: 24137414 Free PMC article.

6

Melanoma differentiation associated gene-7/interleukin-24 induces caspase-3 denitrosylation to facilitate the activation of cancer cell apoptosis.

Tian H, Zhang DF, Zhang BF, Li HZ, Zhang Q, Li LT, Pei DS, Zheng JN. Tian H, et al. Among authors: zhang bf, zhang q, zhang df. J Interferon Cytokine Res. 2015 Mar;35(3):157-67. doi: 10.1089/jir.2014.0061. Epub 2014 Oct 27. J Interferon Cytokine Res. 2015. PMID: 25347351

7

T-cell-associated cellular immunotherapy for lung cancer.

Li K, Zhang Q, Zhang Y, Yang J, Zheng J. Li K, et al. Among authors: zhang q, zhang y. J Cancer Res Clin Oncol. 2015 Jul;141(7):1249-58. doi: 10.1007/s00432-014-1867-0. Epub 2014 Nov 8. J Cancer Res Clin Oncol. 2015. PMID: 25381064 Review.

8

Composite peptide-based vaccines for cancer immunotherapy (Review).

Yang J, Zhang Q, Li K, Yin H, Zheng JN. Yang J, et al. Among authors: zhang q. Int J Mol Med. 2015 Jan;35(1):17-23. doi: 10.3892/ijmm.2014.2000. Epub 2014 Nov 12. Int J Mol Med. 2015. PMID: 25395173 Review.

9

DNA damage response--a double-edged sword in cancer prevention and cancer therapy.

Tian H, Gao Z, Li H, Zhang B, Wang G, Zhang Q, Pei D, Zheng J. Tian H, et al. Among authors: zhang b, zhang q. Cancer Lett. 2015 Mar 1;358(1):8-16. doi: 10.1016/j.canlet.2014.12.038. Epub 2014 Dec 17. Cancer Lett. 2015. PMID: 25528631 Review.

10

A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.

Zhang Q, Zhang Y, Li K, Wang H, Li H, Zheng J. Zhang Q, et al. Among authors: zhang y. PLoS One. 2015 Jun 12;10(6):e0129865. doi: 10.1371/journal.pone.0129865. eCollection 2015. PLoS One. 2015. PMID: 26066322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69,275 results

Search Page

Filters